A new survey from the American Academy of Sleep Medicine reveals that nearly half (45%) of parents have given melatonin to a child under the age of 18 to help him or her sleep.
The University of Arkansas at Little Rock has started a community archaeology project on campus, inviting local residents to join forces with students and faculty in uncovering the rich history of the area.
WashU Medicine scientists lead two large, multicenter programs to develop vaccines and antibody-based therapies for understudied viruses with pandemic potential. The programs are supported by two grants from the National Institute for Allergy and Infectious Diseases (NIAID) totaling more than $30 million a year for three years.
September is National Sickle Cell Awareness Month. Experts from Johns Hopkins Medicine who specialize in sickle cell disease are available to discuss health equity issues related to sickle cell disease.
Heather High, a second-grade teacher and mother of four from Bella Vista, Arkansas, and her 14-year-old son Elijah have something in common – a love of gifted and talented education. High has completed a Master of Education degree in Gifted, Creative, and Talented Education while Elijah has been battling brain cancer.
A distinguished professor emeritus of public affairs, Dr. Roby Robertson, has made a generous donation to create a scholarship for students pursuing a Master of Public Administration at the University of Arkansas at Little Rock.
The latest research and advances in otolaryngology-head and neck surgery will be presented during the AAO-HNSF 2024 Annual Meeting & OTO EXPOSM in Miami, Florida, September 28 – October 1.
Award supports the development of a cell-based assay platform to help scientists discover and test drug candidates for liver fibrosis.
The National Cancer Institute-designated Montefiore Einstein Comprehensive Cancer Center (MECCC) has announced the new Marilyn and Stanley M. Katz Institute for Immunotherapy for Cancer and Inflammatory Disorders. Xingxing Zang, Ph.D., an international leader in developing novel immunotherapies, has been named its inaugural director.
Hackensack Meridian Mountainside Medical Center is honored to announce its selection as a site for the groundbreaking STEMI-DTU Clinical Trial.
Multiyear study finds that high levels of toxic metals in urine lead to high blood sugar
Argon Medical Devices, a leading provider of medical device solutions for Interventional Radiology, Vascular Surgery, Interventional Cardiology, and Oncology procedures, announced the launch of the CLEANER Vac™ Thrombectomy System for the removal of blood clot from the peripheral venous vasculature.
School of Nursing and Health Studies graduates posted a 100 percent first-time pass rate on the national RN licensing exam, according to the latest nursing board data.
People with rare genetic variants associated with Parkinson’s disease and other neurodegenerative disorders are at increased risk of developing amyotrophic lateral sclerosis (ALS), according to new research presented at the 149th Annual Meeting of the American Neurological Association (ANA). The study is the first to find that rare variants linked to other neurodegenerative diseases are associated with ALS, also known as Lou Gehrig’s disease. Researchers also found having these rare variants raises the risk of faster progression of ALS as well as shorter survival.
While colds and flu are detected year round in the U.S., the prevalence of both tends to increase in the fall and winter. Add in COVID-19, and you’ll see a lot of overlap. A Hackensack Meridian Health expert shares what you need to know to be ready for the season.
Starting patients with multiple sclerosis (MS) on aggressive treatment earlier may help prevent the development of paramagnetic rim lesions (PRL), areas of chronic brain inflammation that are linked to faster decline due to the disease, suggests new research presented at the 149th Annual Meeting of the American Neurological Association (ANA). People with MS who have PRLs tend to have greater brain atrophy and disability. Treatment for MS includes low-, moderate- or high-efficacy disease-modifying therapies (DMTs), such as monoclonal antibodies, immunomodulators and immunosuppressants. While high-efficacy DMTs have more side effects, previous research suggests they may help prevent PRLs from forming (unlike low- or moderate-efficacy DMTs), potentially outweighing the downsides. No currently available DMT has been shown to reduce existing PRLs.
Over half of parents report at least one factor that makes it difficult for their child to make new friends, with about one in five saying that shyness or being socially awkward got in the way of their child’s efforts to make new friends.
They’re the tips and tricks usually learnt on the job, but thanks to a new reading initiative, pre-service teachers at the University of South Australia are gaining valuable insights about how to build students’ reading and literacy skills from experienced teachers on the job.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right